Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mechanical approaches to alter remodeling.

Sunil Matiwala1, Kenneth B Margulies

  • 1Temple University School of Medicine, 3420 North Broad Street, Philadelphia, PA 19140, USA.

Current Heart Failure Reports
|July 23, 2005
PubMed
Summary

Cardiovascular devices significantly improve reverse remodeling in dilated cardiomyopathies, offering a more rapid and reliable approach than medications. These devices, including ventricular assist devices and pacing, effectively reduce cardiac dilation and hypertrophy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Load-Dependent Effects of Sodium Glucose Co-Transporter Inhibitors on Work in Human Hypertrophic Cardiomyopathy Living Myocardial Slices.

bioRxiv : the preprint server for biology·2026
Same author

Stiffness-induced impairment of GLUT4 trafficking in adult cardiomyocytes.

Cell reports·2026
Same author

STING promotes CD8 T-cell cardiotropism and fibrosis from distinct cellular compartments in doxorubicin cardiomyopathy.

Cardiovascular research·2026
Same author

Patching Up Damaged Hearts.

The New England journal of medicine·2026
Same author

Targeting Arrhythmogenic Late Sodium Current by FHF1<sub>A</sub>-Derivative FixR in Heart Failure Cardiomyocytes.

Circulation research·2026
Same author

Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.

Hypertension (Dallas, Tex. : 1979)·2026

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Regenerative Medicine

Background:

  • Pathologic cardiac hypertrophy and dilation, termed reverse remodeling, are key therapeutic targets for dilated cardiomyopathies.
  • Pharmacologic therapies offer limited regression of cardiac remodeling.
  • Cardiovascular devices show promise for more effective reverse remodeling.

Purpose of the Study:

  • To review the role and efficacy of cardiovascular devices in promoting reverse remodeling.
  • To compare device-associated reverse remodeling with pharmacologic approaches.
  • To highlight the potential of passive cardiac support devices.

Main Methods:

  • Review of existing literature on cardiovascular devices for dilated cardiomyopathies.
  • Analysis of data from studies utilizing left ventricular assist devices.

Related Experiment Videos

  • Examination of clinical efficacy of multisite ventricular pacing.
  • Evaluation of passive cardiac support strategies.

    • Main Results:

    • Left ventricular assist devices induce dramatic reverse remodeling in advanced heart failure.
    • Multisite ventricular pacing reduces cardiac dilation and hypertrophy, improving symptoms and function.
    • Passive cardiac support devices present a promising strategy for preventing or reversing remodeling.

    Conclusions:

    • Cardiovascular devices offer a more rapid and reliable method for reverse remodeling compared to pharmacologic treatments.
    • Left ventricular assist devices and multisite ventricular pacing are effective interventions.
    • Passive cardiac support devices represent a novel and promising therapeutic avenue for dilated cardiomyopathies.